1. Metabolically healthy obese and MAFLD: does weight status alone matter?

   • Ziyan Pan
   • Mohammed Eslam

   Editorial 17 October 2022 Pages: 1253 - 1255

2. Platelets in acute liver failure: an innocent bystander or instigator?

   • Rakhi Maiwall

   Editorial 04 October 2022 Pages: 1256 - 1258

3. Diversity of the nucleic acid forms of circulating HBV in chronically infected patients and its impact on viral cycle

   • Jules Sotty
   • Pierre Bablon
   • Patrick Soussan

   Original Article 04 August 2022 Pages: 1259 - 1272

   

4. New progress towards elimination of mother-to-child transmission of hepatitis B virus in China

   • Hui Zheng
   • Nick Walsh
   • Fuqiang Cui

   Original Article 18 October 2022 Pages: 1273 - 1281

   

5. Countdown on hepatitis B elimination by 2030: the global burden of liver disease related to hepatitis B and association with socioeconomic status

   • Guiying Cao
   • Wenzhan Jing
   • Min Liu

   Original Article 01 September 2022 Pages: 1282 - 1296

   

6. Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort

   • Yao-Chun Hsu
   • Dae Won Jun
   • Mindie H. Nguyen

   Original Article 07 September 2022 Pages: 1297 - 1307

   

7. Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population

   • Hokyou Lee
   • Tae Seop Lim
   • Hyeon Chang Kim

   Original Article 07 September 2022 Pages: 1308 - 1317

   

8. Drug–drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study

   • Vicki Wing-Ki Hui
   • Christopher Langjun Au
   • Grace Lai-Hung Wong

   Original Article 08 September 2022 Pages: 1318 - 1329

   

9. Prognosis factors of predicting survival in spontaneously ruptured hepatocellular carcinoma

   • Peng Wang
   • Abraham S Moses
   • Xiang-jun Han

   Original Article Open access 25 August 2022 Pages: 1330 - 1338

   

10. Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma

    • Linghao Zhao
    • Yuyouye Wang
    • Weiping Zhou

    Original Article Open access 20 September 2022 Pages: 1339 - 1352

    

11. A proposal for T1 subclassification in hepatocellular carcinoma: reappraisal of the AJCC 8th edition

    • Chao-Wei Lee
    • Hsin-I Tsai
    • Hsing-Yu Chen

    Original Article Open access 28 September 2022 Pages: 1353 - 1367

    

12. Radiotherapy prior to or after transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a randomized controlled trial

    • Lei Guo
    • Xubiao Wei
    • Shuqun Cheng

    Original Article 21 October 2022 Pages: 1368 - 1378

    

13. Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker

    • Yan Chen
    • Xuemei Ma
    • Yongping Yang

    Original Article 18 October 2022 Pages: 1379 - 1389

    

14. Etiology, outcome and prognostic indicators of acute liver failure in Asian children

    • Ruey Terng Ng
    • Kee Seang Chew
    • Way Seah Lee

    Original Article 21 September 2022 Pages: 1390 - 1397

    

15. Reduction of natural killer cells is associated with poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure

    • Hua-Jie Li
    • Ning Yang
    • Fu-Sheng Wang

    Original Article 15 September 2022 Pages: 1398 - 1411

    

16. Association between metabolically healthy obesity and non-alcoholic fatty liver disease

    • Sailimai Man
    • Jun Lv
    • Hui Liu

    Original Article 20 August 2022 Pages: 1412 - 1423

    

17. Effects of serum branched-chain amino acids on nonalcoholic fatty liver disease and subsequent cardiovascular disease

    • Fei Guo
    • Rui Chen
    • Wen Hu

    Original Article 18 July 2022 Pages: 1424 - 1434

    

18. Development and experimental verification of a prognosis model for cuproptosis-related subtypes in HCC

    • Yixiu Wang
    • Yongfa Zhang
    • Lu Wang

    Original Article 05 September 2022 Pages: 1435 - 1447

    

19. The clinical implications of pre-liver transplant diabetes on post-liver transplant outcomes in patients with NASH: analysis of the UNOS database

    • David Uihwan Lee
    • John Han
    • Nathalie H. Urrunaga

    Original Article 11 September 2022 Pages: 1448 - 1457

    

20. Two-year risedronate treatment for osteoporosis in patients with esophageal varices: a non-randomized clinical trial

    • Lívia Alves Amaral Santos
    • Talles Bazeia Lima
    • Fernando Gomes Romeiro

    Original Article 29 June 2022 Pages: 1458 - 1467

    

21. Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials

    • Zhaohui Bai
    • Le Wang
    • Xingshun Qi

    Original Article 01 September 2022 Pages: 1468 - 1483

    

22. Identification of blood metabolites linked to the risk of cholelithiasis: a comprehensive Mendelian randomization study

    • Jiarui Mi
    • Lingjuan Jiang
    • Xiaoyin Bai

    Original Article 15 June 2022 Pages: 1484 - 1493

    

23. Correction to: Linking the gut and liver: crosstalk between regulatory T cells and mucosa-associated invariant T cells

    • Muhammad Atif
    • Suz Warner
    • Ye H. Oo

    Correction 05 September 2022 Pages: 1494 - 1495

    

24. Correction to: Infuence of shunt occlusion on liver volume and functions in hyperammonemic cirrhosis patients having large porto-systemic shunts: a randomized control trial

    • Amar Mukund
    • Shakti Prasad Choudhury
    • Shiv Kumar Sarin

    Correction 10 October 2022 Pages: 1496 - 1498